Academic literature on the topic 'Tocolytic effects'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Tocolytic effects.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Tocolytic effects"

1

Lee, Howard Hao, Chang-Ching Yeh, Szu-Ting Yang, Chia-Hao Liu, Yi-Jen Chen, and Peng-Hui Wang. "Tocolytic Treatment for the Prevention of Preterm Birth from a Taiwanese Perspective: A Survey of Taiwanese Obstetric Specialists." International Journal of Environmental Research and Public Health 19, no. 7 (2022): 4222. http://dx.doi.org/10.3390/ijerph19074222.

Full text
Abstract:
Preterm birth represents a great burden to the healthcare system, resulting in the consideration for the use of tocolytic therapy to provide a “better time” for delivery in order to buy time to accelerate fetal lung maturity, thereby minimizing prematurity-related morbidity and mortality. However, the benefits and potential side effects and risks of tocolytic treatment for preterm birth should be carefully balanced. Although many countries and societies provide guidelines or consensuses for the management for preterm birth, there is no standardized national guideline or consensus in Taiwan. As
APA, Harvard, Vancouver, ISO, and other styles
2

Nasreen, Sk Zinnat Ara, Safinaz Shahreen, and Shahnaz Rahman. "Recent Update on Tocolytics for the Management of Preterm Labour." Bangladesh Journal of Obstetrics & Gynaecology 27, no. 1 (2016): 21–26. http://dx.doi.org/10.3329/bjog.v27i1.29910.

Full text
Abstract:
Tocolysis is the relaxation of the pregnant uterus to postpone delivery. Tocolytics are a wide variety of agents used to suppress uterine contraction given when delivery would result in preterm birth. Preterm birth the most important single determinant of adverse outcome in terms of both survival and quality of life of baby. Although preterm birth is defined as being before 37 completed weeks most mortality and morbidity is experienced by babies born before 34 weeks. Prevention and treatment of preterm birth is important though it is not possible when labour is too advanced, cervix is dilated
APA, Harvard, Vancouver, ISO, and other styles
3

Coler, Brahm Seymour, Oksana Shynlova, Adam Boros-Rausch, et al. "Landscape of Preterm Birth Therapeutics and a Path Forward." Journal of Clinical Medicine 10, no. 13 (2021): 2912. http://dx.doi.org/10.3390/jcm10132912.

Full text
Abstract:
Preterm birth (PTB) remains the leading cause of infant morbidity and mortality. Despite 50 years of research, therapeutic options are limited and many lack clear efficacy. Tocolytic agents are drugs that briefly delay PTB, typically to allow antenatal corticosteroid administration for accelerating fetal lung maturity or to transfer patients to high-level care facilities. Globally, there is an unmet need for better tocolytic agents, particularly in low- and middle-income countries. Although most tocolytics, such as betamimetics and indomethacin, suppress downstream mediators of the parturition
APA, Harvard, Vancouver, ISO, and other styles
4

O'Donnell, James, and Leslie Iffy. "Cardiopulmonary Adverse Effects of Oral and Subcutaneous Terbutaline for Tocolysis." Journal of Pharmacy Practice 9, no. 3 (1996): 181–87. http://dx.doi.org/10.1177/089719009600900305.

Full text
Abstract:
Are there differences between the expected or reported adverse reactions associated with terbutaline when administered orally as opposed to the parenteral routes (such as subcutaneously or intravenously)? This is a report on a pulmonary edema and subsequent death of a laboring woman who was treated with a combination of tocolytic agents in an attempt to prolong the gestation. The agents included magnesium sulfate, and subcutaneous and oral terbutaline. The intention is to alert the reader to the cardiovascular risks associated with combining tocolytic agents, and to dispel a pervasive myth tha
APA, Harvard, Vancouver, ISO, and other styles
5

Jeswani, Rohit, Yamini Patil, Sangeeta Lalwani, and Monika Dudve. "A Comparative Study Between Intravenous Magnesium Sulphate and Intravenous Isoxsuprine for Arrest of Preterm Labour." National Journal of Medical Research 14, no. 01 (2024): 11–16. http://dx.doi.org/10.55489/njmr.14012024988.

Full text
Abstract:
Introduction: Wide use of medical management of preterm labour has been obstructed due to low success rate of arrest of labour. This is aggravated by higher incidence of serious side effect of the available tocolytic agents, especially beta-mimetic tocolytics. With this background, the present study was carried out to compare the efficacy and maternal side effect of magnesium sulphate and Isoxsuprine in the arrest of preterm labour
 Methodology: This was a comparative prospective interventional study conducted among pregnant women coming to department of obstetrics and gynaecology with 28
APA, Harvard, Vancouver, ISO, and other styles
6

Kirchhoff, Ebba, Verena Schneider, Gerhard Pichler, et al. "Hexoprenaline Compared with Atosiban as Tocolytic Treatment for Preterm Labor." Geburtshilfe und Frauenheilkunde 82, no. 08 (2022): 852–58. http://dx.doi.org/10.1055/a-1823-0176.

Full text
Abstract:
Abstract Introduction Preterm birth is defined as a live birth before 37 weeks of gestation and is associated with increased neonatal morbidity and mortality. The aim of this study is to compare the efficacy of hexoprenaline and atosiban for short- and long-term tocolysis and their effects on neonatal and maternal outcomes. Methods This retrospective cohort study included women with threatened preterm labor between 24 + 0 and 34 + 0 weeks of gestation without premature rupture of membranes. The tocolytic efficacy of hexoprenaline and atosiban was compared in women receiving one of the two medi
APA, Harvard, Vancouver, ISO, and other styles
7

Baev, O. R., O. N. Vasilchenko, and A. O. Karapetyan. "Modern tocolysis and adverse effects of tocolytics." Gynecology 20, no. 2 (2018): 46–50. http://dx.doi.org/10.26442/2079-5696_2018.2.46-50.

Full text
Abstract:
Relevance. Toсolytic therapy is the only method that is used in the treatment of pregnant women with preterm labor. However, the effectiveness and safety of this therapy is still a matter of debate. One of the least studied issues of this problem is the safety of therapy, which is primarily manifested by the frequency of side effects. The aim is to carry out a comparative study of the safety of the most common tocolytic agents - atosiban, nifedipine and hexoprenaline sulfate. Material and methods. The study included 173 pregnant women with threatening premature births in a period of 28 to 34 w
APA, Harvard, Vancouver, ISO, and other styles
8

Gureeva, L. V., O. M. Chistyakova, E. K. Paramonova, and O. V. Radkov. "Influence of Tocolytic Therapy with Hexoprenaline on Heart Rate Variability, Lipid Spectrum and Glycemic Level in Obese Pregnant Women." Acta Biomedica Scientifica 6, no. 1 (2021): 7–12. http://dx.doi.org/10.29413/abs.2021-6.1.1.

Full text
Abstract:
Background. Obesity is associated with the risk of spontaneous preterm birth. Hexoprenaline is the effective and most widely used tocolytic agent, possessing however a significant number of side effects. The effect of hexoprenaline tocolysis on heart rate variability, lipid spectrum and glycaemia level in obese pregnant women remain unexplored.Aim of the research. To study the effect of tocolytic therapy with hexoprenaline on heart rate variability, lipid spectrum and glycemic level in obese pregnant women.Materials and methods. The study included two groups of pregnant women with threatened p
APA, Harvard, Vancouver, ISO, and other styles
9

Yamaji, Noyuri, Hitomi Suzuki, Kana Saito, et al. "Tocolytic Therapy Inhibiting Preterm Birth in High-Risk Populations: A Systematic Review and Meta-Analysis." Children 10, no. 3 (2023): 443. http://dx.doi.org/10.3390/children10030443.

Full text
Abstract:
This systematic review aimed to identify the benefits and possible harms of tocolytic therapy for preterm labour management in the context of pregnant women with extremely preterm birth, multiple gestations, or growth-restricted foetuses. A comprehensive search using MEDLINE, Embase, the Cochrane Central Register of Controlled Trials, CINAHL, and the WHO Global Index Medicus databases was conducted from 10 to 15 July 2021. We included randomized controlled trials and non-randomized studies that assessed the effects of tocolysis compared with placebo or no treatment. We found 744 reports and, f
APA, Harvard, Vancouver, ISO, and other styles
10

Patil, Yamini, Padmaja A. Havle, Shivaji V. Raje, and Gauri Shinde. "Preterm Labor with Side Effects: Compare the Effectiveness of Magnesium Sulfate (MgSO4) with Isoxsuprine." INTERNATIONAL JOURNAL OF PHARMACEUTICAL QUALITY ASSURANCE 14, no. 03 (2023): 786–90. http://dx.doi.org/10.25258/ijpqa.14.3.55.

Full text
Abstract:
Background: In India, 25% of pregnancies develop preterm labor (PTL), resulting in 10 to 69% cases of preterm birth. Medical intervention to stop labor, reduce infection rate, and avoid infant respiratory distress has been the subject of studies for a long time. PTL patients usually get tocolytics, corticosteroids, antibiotics, and other clinically symptomatic and supportive therapy to accomplish this goal. Studies further showed that these tocolytic drugs lower intracellular calcium bioavailability via biochemical pathways, hindering the interaction of actin-myosin. Due to the poor success ra
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Tocolytic effects"

1

Al-Eknah, Marzook Mohammed. "Uterine activity in the ewe and cow, with particular reference to its effect on cervical dilation and the influence of tocolytic agents." Thesis, Royal Veterinary College (University of London), 1988. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.518063.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Shih, Huey-Chuan, and 施惠娟. "Tocolytic Effects of Scutellaria baicalensis in Rat Uterus." Thesis, 2000. http://ndltd.ncl.edu.tw/handle/33892961606989661204.

Full text
Abstract:
碩士<br>台北醫學院<br>生藥學研究所<br>88<br>Chinese medicinal prescriptions have been used commonly in treatment of several human diseases for thousands of years in China. Huang qin, the dried root of Scutellaria baicalensis Georgi, has been used as a tocolytic agent and prescribed by Chinese medical doctors to treatment the contractive disorders in pregnant women. However, the scientific action mechanism of Huang Qin is undefined. Our preliminary data indicated that aqueous crude extract of Huang Qin exerted the significant relaxation on spontaneous constriction in 10-day pregnant rat uterus smooth muscle
APA, Harvard, Vancouver, ISO, and other styles
3

Chang, Te-Hsin, and 張德馨. "The Medical Effects and Cost of Hospitalized Tocolysis on Neonatal Babies." Thesis, 2011. http://ndltd.ncl.edu.tw/handle/99103951251993243726.

Full text
Abstract:
碩士<br>國立陽明大學<br>醫務管理研究所<br>99<br>Objective The essential goal of preventing premature infants’ complications is to increase the gestational weeks and reduce the incidence of preterm birth on pregnant woman with tendency of preterm birth. This study was to examine the difference of characteristics of the maternal and newborn, birth outcomes, and medical utilizations between the short-term tocolysis (≦2days) and long-term tocolysis (>2days). The results will be a reference for tocolytics care policy. Methods A retrospective study was designed to compare the complications of the maternal and new
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Tocolytic effects"

1

1933-, Tejani Nergesh, ed. Obstetrical events and developmental sequelae. 2nd ed. CRC Press, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Tocolytic effects"

1

Hildebrandt, Ruth. "Risk Assessment of Tocolytic Therapy in Pregnancy." In Risk Assessment of Prenatally-Induced Adverse Health Effects. Springer Berlin Heidelberg, 1992. http://dx.doi.org/10.1007/978-3-642-77753-0_37.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Haikera, Hertha Kasiku, Larai Aku-Akai, and Yapo Guillaume Aboua. "Scope of Medicinal Plants for Uterotonic, Tocolytic, and Wellness Effects in Pregnant Women: A Cultural Perspective." In Curative and Preventive Properties of Medicinal Plants. Apple Academic Press, 2023. http://dx.doi.org/10.1201/9781003328544-24.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Al-Jindi, Piotr, and Bethany Potere. "Tocolytic Drugs." In Advanced Anesthesia Review, edited by Alaa Abd-Elsayed. Oxford University PressNew York, 2023. http://dx.doi.org/10.1093/med/9780197584521.003.0284.

Full text
Abstract:
Abstract Tocolytic agents are agents that inhibit uterine contraction and allow enough time for corticosteroids to help with lung maturation. They are administered in cases of premature labor between the 22nd and 34th weeks of gestational age. They are divided into betamimetics, calcium channel blockers, cyclooxygenase inhibitors, and magnesium sulfate. Betamimetics can be used for a short period of time; their prolonged use is not recommended due to extensive side effects, including maternal death. They are associated with pulmonary edema, tachycardia, arrhythmias, hyperglycemia, and hypokale
APA, Harvard, Vancouver, ISO, and other styles
4

Kshirsagar, N. S., Manisha Laddad, Sanjay Kumar S. Patil, and Abeer Alatawi. "Comparative Evaluation of Tocolytic Efficacy on Oral Nifedipine Tablet vs. Transdermal Nitroglycerine Patch in Preterm Labor." In Clinical and Comparative Research on Maternal Health. IGI Global, 2024. http://dx.doi.org/10.4018/979-8-3693-5941-9.ch008.

Full text
Abstract:
Because preterm labour is linked to poor outcomes for newborns, it is a major concern in obstetrics. Tocolytic medicines are used to improve foetal outcomes and delay preterm birth. Oral nifedipine and transdermal nitroglycerine are compared for tocolytic efficacy, safety, and cost-effectiveness in premature labour control. A randomised controlled trial included 200 preterm-risk pregnant women. One group received transdermal nitroglycerine and the other oral nifedipine. Minimum 48-hour delivery delay was the main consequence. Secondary outcomes included neonatal outcomes, mother side effects,
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!